Hoth Therapeutics reported interim trial results showing all patients improved by Week 6, with reduced disease severity, ...
Dr. Breelyn Wilky explains how vague symptoms and testing challenges delay GIST diagnoses; however, molecular testing can help guides treatment decisions. Dr. Breelyn Wilky, an associate professor of ...
PEAK trial first ever study to demonstrate statistical significance over an active comparator in GIST patients, with bezuclastinib plus ...
GSK plc (NYSE:GSK) agreed to acquire IDRx, Inc., a biopharmaceutical company focused on precision therapeutics for gastrointestinal stromal tumors (GIST), for $1 billion. Under the agreement, GSK ...
Surgery and chemotherapy together improved survival in GIST patients with liver metastases, increasing median cancer-specific ...
Hoth Therapeutics Inc. has released preclinical findings demonstrating the efficacy of HT-KIT, a novel targeted therapy for gastrointestinal stromal tumors (GIST).
BLOOMINGTON, Minn.--The GIST Cancer Research Fundraiser is Friday, August 4 at the Knights of Columbus from 7:00 p.m.-10:00 p.m. Proceeds provide support to those with Gastro Intestinal Stromal Tumors ...
Ailing barber Samuel Kilonzi, popularly known as Kitiki Sam, has once again opened up about his painful battle with cancer as he marks his birthday. Kitiki has been fighting cancer for the past year, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results